This announcement is a separate document:
四環醫藥：採納二零二二年股份獎勵計劃及有關二零二一年年報之補充資料
SIHUAN PHARM: ADOPTION OF THE 2022 SHARE AWARD SCHEME AND SUPPLEMENTAL INFORMATION IN RELATION TO THE 2021 ANNUAL REPORT
Oct 26, 2022 22:51
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.